Anaesthetic management in a neonate with congenital complete heart block

Paediatric Anaesthesia

Volumn 14, Issue 2, 2004, Pages 172-175

  Castilla, Mariano ^a,b   Jerez, Marta ^a   Llácer, Manuel ^a   Martinez, Sandra ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b NONE   (Spain)

Author keywords

Anaesthetic management; Congenital complete heart block; Systemic lupus erythematosus

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIPYRONE; ISOPRENALINE; KETAMINE; SEVOFLURANE;

ANAMNESIS; ANESTHESIA; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BREATHING; CASE REPORT; COMPLETE HEART BLOCK; DRUG INFUSION; GENERAL ANESTHESIA; GESTATIONAL AGE; HEART RATE; HUMAN; HYDRAMNIOS; LARYNGEAL MASK; MALE; MORPHOLOGY; NEWBORN; NEWBORN DISEASE; OXYGEN SATURATION; PERFUSION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STERNOTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANALGESICS; ANESTHESIA, GENERAL; ANESTHETICS, INHALATION; APNEA; HEART BLOCK; HEART RATE; HUMANS; INFANT, NEWBORN; KETAMINE; LARYNGEAL MASKS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHYL ETHERS; PACEMAKER, ARTIFICIAL; POSTOPERATIVE COMPLICATIONS;

EID: 1542359042     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.01180.x     Document Type: Article

References (36)

1. Anisman PC. Cardiac dysrhythmias. In: Spitzer AR, ed. Intensive Care of the Fetus and Neonato. St Louis: Mosby, 1996: 797-822.
2. Michaelson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 1972; 4: 85-101.
3. Alexander E, Buyon JP, Provost TT et al. Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum 1992; 35: 176-189.
4. Scheib JS, Waxman J. Congenital heart block in successive pregnancies: a case report and evaluation of risk with therapeutic consideration. Obstet Gynecol 1989; 73: 481-484.
5. Horsfall AC, Neu E, Forrest G et al. Maternal autoantibodies and congenital heart block: clues from two consecutive pregnancies, one in which there was congenital complete heart block and one in which the fetus was healthy. Arthritis Rheum 1998; 41: 2079-2080.
6. Buyon JP, Winchester RJ, Slade SG et al. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 1993; 36: 1943-1950.
7. Aldrete JA, Kroulik D. A postanesthetic recovery score. Anesth Analg 1970; 49: 924-934.
8. Buyton JP, Waltuck J, Caldwell K et al. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 53 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block. J Rheumatol 1994; 21: 1243-1250.
9. Lee LA, Coulter S, Erner S et al. Cardiac inmunoglobulin deposition in congenital heart block associated with maternal anti-Ro autoantibodies. Am J Med 1987; 83: 793-796.
10. Ho SY, Fagg N, Anderson RH et al. Disposition of the atrioventricular conduction tissues in the heart with isomerism of the atrial appendages: its relation to congenital complete heart block. J Am Coll Cardiol 1992; 20: 904-910.
11. Gordon PA, Rosenthal E, Khamashta M et al. Absence of conduction defects in the echocardiograms of mothers with children with congenital complete heart block. J Rheumatolol 2001; 28: 366-369.
12. Brucato A, Frassi M, Franco F et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-1835.
13. Buyon JP, Hiebert R, Copel J et al. Autoimmune-associated congenital heart block: demographics, mortality and recurrence rates obtained from a national neonal lupus registry. J Am Coll Cardiol 1998; 31: 1658-1666.
14. Gladman G, Silverman ED, Yuk-Law et al. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies. Am J Perinatol 2002; 19: 73-80.
15. Groves AM, Allan LD, Rosenthal E. Therapeutic trial of sympathicomimetics in three cases of complete heart block in the fetus. Circulation, 1995; 92: 3394-3396.
16. Shinohara K, Miyagawa S, Fujita T et al. Neonatal lupus erythematosus:results of maternal corticosteriod therapy. Obstet Gynecol 1999; 93: 952-957.
17. Copel JA, Buyon JP, Kleinman CS. Sucessful in utero therapy of fetal heart block. Am J Obstet Gynecol 1995; 173: 1384-1390.
18. Eronen M, Heikklia P, Teramo K. Congenital complete heart block in the fetus: hemodynamic features, antenatal treatment, and outcome in six cases. Pediatr Cardiol 2001; 22: 385-392.
19. Friedman RA. Congenital AV block. Pace me now or pace me later? Circulation 1995; 92: 283-285.
20. Diaz JH, Friesen RH. Anesthetic management of congenital complete heart block in childhood. Anesth Analg 1979; 58: 334-335.
21. Ebert TJ, Harkin CP, Muzi M. Cardiovascular responses to sevoflurane: a review. Anesth Analg 1995; 81: S11-S22.
22. Piat V, Dubois MC, Johanet S et al. Induction and recovery characteristics and hemodynamic responses to sevoflurane and halothane in children. Anesth Analg 1994; 79: 840-844.
23. Kawana S, Wachi J, Nakayama M et al. Comparison of haemodinamic changes induced by sevoflurane and halothane in paediatric patients. Can J Anaesth 1995; 42: 603-607.
24. Kern C, Erb T, Frei FJ. Haemodynamic responses to sevoflurane compared with halothane during inhalational induction in children. Paediatr Anaesth 1997; 7: 439-444.
25. Sarner JB, Levine M, Davis PJ et al. Clinical characteristics of sevoflurane in children. A comparison with halothane. Anesthesiology 1995; 82: 38-46.
26. Lopez Gil M, Brimacombe J, Clar B. Sevoflurane versus propofol for induction and maintenance of anaesthesia with the larygeal mask airway in children. Paediatr Anaesth 1999; 9: 491-499.
27. Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth 1998; 9: 349-351.
28. Sochala C, Deenen D, Ville A et al. Heart block following propofol in a child. Paediatr Anaesth 1999; 9: 349-351.
29. Epstein RH, Mendel HG, Guarnieri KM et al. Sevoflurane versus halothane for general anesthesia in pediatric patients: a comparative study of vital signs, induction, and emergence. J Clin Anesth 1995; 7: 237-244.
30. Reich DL, Silvay G. Ketamine: an update on the first 25 years of clinical experience. Can J Anaesth 1998; 36: 186-197.
31. Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg 1998; 87: 1186-1193.
32. Reboso Morales JA, Gonzalez Miranda F. Ketamine. Rev Esp Anestesiol Reanim 1999; 46: 111-122.
33. Raeder JC, Stenseth LB. Ketamine: a new look at an old drug. Curr Opin Anaesth 2000; 13: 463-468.
34. Sarma VJ. Use of ketamine in acute severe asthma. Acta Anaeshesiol Scand 1992; 36: 106-107.
35. Eronen M, Siren MK, Ekbland H et al. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as newborn. Pediatrics 2000; 106: 86-91.
36. Moak JP, Barron KS, Hougen TJ et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001; 37: 238-242.